Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.56 |
| ▸ | GSK3A | P49840 | 3/20 | 0.50 |
| ▸ | GSK3B | P49841 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.46 |
| ▸ | CDK1 | P06493 | 1/20 | 0.46 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.46 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.46 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | PLG | P00747 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4584939 | 1.00 | CYP3A4 (0.61) | CYP3A4ADORA3ADORA2AADORA1GSK3A | |
| SCHEMBL11033311 | 0.90 | CYP3A4 (0.70) | CYP3A4ADORA3ADORA2AADORA1KDM4E | |
| SCHEMBL1284803 | 0.85 | CYP3A4 (0.61) | CYP3A4ADORA3ADORA2AADORA1KDM4E | |
| SCHEMBL8985073 | 0.83 | GSK3B (0.67) | CYP3A4GSK3AGSK3BKDM4EMAPT | |
| SCHEMBL17154512 | 0.81 | CYP3A4 (0.57) | CYP3A4ADORA3ADORA2AADORA1GSK3A | |
| SCHEMBL31122814 | 0.80 | ADORA3 (0.46) | CYP3A4ADORA3ADORA2AADORA1KDM4E | |
| SCHEMBL5049130 | 0.79 | CYP3A4 (0.59) | CYP3A4GSK3AGSK3BKDM4EMAPT | |
| SCHEMBL28662 | 0.78 | CYP3A4 (1.00) | CYP3A4ADORA3ADORA2AKDM4EMAPT | |
| SCHEMBL29507760 | 0.78 | CYP3A4 (0.62) | CYP3A4KDM4EL3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL6695468 | 0.78 | CYP3A4 (0.62) | CYP3A4KDM4EL3MBTL1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3528046-B1 | POSITIVE PHOTOSENSITIVE COMPOSITION AND THIN FILM TRANSISTOR | KANEKA CORP (JP) | 2020-09-09 | — | — | EP | disclosed |
| EP-3528046-A1 | POSITIVE PHOTOSENSITIVE COMPOSITION AND THIN FILM TRANSISTOR | Kaneka Corporation (JP) | 2019-08-21 | — | — | EP | disclosed |
| EP-2871523-B1 | POSITIVE PHOTOSENSITIVE COMPOSITION AND THIN FILM TRANSISTOR | KANEKA CORP (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-9793456-B2 | Molded resin body for surface-mounted light-emitting device, manufacturing method thereof, and surface-mounted light-emitting device | KANEKA CORPORATION (JP) | 2017-10-17 | — | — | US | disclosed |
| US-9588425-B2 | Positive photosensitive composition, thin film transistor, and compound | KANEKA CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| US-20170023861-A1 | POSITIVE PHOTOSENSITIVE COMPOSITION, THIN FILM TRANSISTOR, AND COMPOUND | KANEKA CORP (JP) | 2017-01-26 | — | — | US | disclosed |
| US-9494861-B2 | Positive photosensitive composition, thin film transistor, and compound | KANEKA CORPORATION (JP) | 2016-11-15 | — | — | US | disclosed |
| US-9496468-B2 | Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode | KANEKA CORPORATION (JP) | 2016-11-15 | — | — | US | disclosed |
| EP-1803761-B1 | Ring-opened copolymer, hydrogenated ring-opened copolymer, process for producing thereof, and compositions | ZEON CORP (JP) | 2016-04-27 | — | — | EP | disclosed |
| US-9178120-B2 | Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode | KANEKA CORPORATION (JP) | 2015-11-03 | — | — | US | disclosed |
| EP-1609835-A1 | CURING COMPOSITION AND METHOD FOR PREPARING SAME, LIGHT-SHIELDING PASTE, LIGHT-SHIELDING RESIN AND METHOD FOR PRODUCING SAME, PACKAGE FOR LIGHT-EMITTING DIODE, AND SEMICONDUCTOR DEVICE | KANEKA CORPORATION (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-6955848-B2 | Curable composition and multilayered circuit substrate | ZEON CORPORATION (JP) | 2005-10-18 | — | — | US | disclosed |
| US-20050209400-A1 | 1,3,5,7-tetramethylcyclotetrasiloxane and triallyl isocyanurate, a hydrosilylation catalyst, a silane coupling agent and/or an epoxy group-containing compound, and a silanol condensation catalyst | KANEKA CORPORATION (JP) | 2005-09-22 | — | — | US | disclosed |
| EP-1505121-A1 | HARDENABLE COMPOSITION, HARDENING PRODUCT, PROCESS FOR PRODUCING THE SAME AND LIGHT EMITTING DIODE SEALED WITH THE HARDENING PRODUCT | KANEKA CORPORATION (JP) | 2005-02-09 | — | — | EP | disclosed |
| US-20040152843-A1 | Open-ring copolymer, hydrogenated open-ring copolymer, process for production of both, and compositions | ZEON CORPORATION (JP) | 2004-08-05 | — | — | US | disclosed |
| EP-1408064-A1 | OPEN-RING COPOLYMER, HYDROGENATED OPEN-RING COPOLYMER, PROCESSES FOR PRODUCTION OF BOTH, AND COMPOSITIONS | Zeon Corporation (JP) | 2004-04-14 | — | — | EP | disclosed |
| US-20040029043-A1 | Process for producing circuit substrates | ZEON CORPORATION (JP) | 2004-02-12 | — | — | US | disclosed |
| US-20040025743-A1 | Curable composition, varnish, and layered product | ZEON CORPORATION (JP) | 2004-02-12 | — | — | US | disclosed |
| US-20030146421-A1 | Curable composition and multilayered circuit substrate | ZEON CORPORATION (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-1275695-A1 | CURABLE COMPOSITION AND MULTILAYERED CIRCUIT SUBSTRATE | Zeon Corporation (JP) | 2003-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170023861-A1 | POSITIVE PHOTOSENSITIVE COMPOSITION, THIN FILM TRANSISTOR, AND COMPOUND | ASIC3, ASIC1, HCN4 | CYP3A4 2917/4885ADORA3 2964/4885ADORA2A 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.